An American Academy of Facial Plastic and Reconstructive Surgery survey finds 60% of facial plastic surgeons report an increase in patients with “Ozempic Face,” a side effect of weight loss drug Semaglutide, with treatment options including fillers, lifts, and fat grafting, while long-term outcomes remain uncertain.